Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin glargine |
Is a |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
rekombinant humant insulinanalogpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
1 |
Product containing insulin glargine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Insulin glargine 100u/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
insulin glargin (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Insulin glargine 100iu/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
rekombinant human insulin NPH-analog |
Is a |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Recombinant human regular insulin (substance) |
Is a |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
langtidsvirkende rekombinant humant zinkinsulin |
Is a |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Product containing insulin glulisine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
isofaninsulin NPH + rekombinant human insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
insulin glulisin 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Product containing insulin detemir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Insulin detemir 100iu/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
Insulin detemir 100iu/mL injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|
insulin glulisin 100 IE/ml injektionsvæske, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rekombinant human insulinanalog |
Inferred relationship |
Some |
|